17089-067 NDC - ANTI AGE STRESS (ACETYLCYSTEINE - BALLOTA FOETIDA - EPINEPHRINE - GLUTATHIONE - INTERFERON GAMMA-1B - LENOGRASTIM - LITHIUM CARBONATE - MELATONIN - PENICILLIUM GLABRUM - POTASSIUM CARBONATE - PUMMELO - RHODOTORULA RUBRA - SILVER NITRATE - STRYCHNOS NUX-VOMICA SEED - SUS SCROFA CEREBRAL CORTEX - SUS SCROFA STOMACH - SUS SCROFA SUPERIOR GASTRIC PLEXUS - SUS SCROFA THALAMUS -)

Drug Information

  • Product NDC: 17089-067
  • Proprietary Name: ANTI AGE STRESS
  • Non Proprietary Name: acetylcysteine - ballota foetida - epinephrine - glutathione - interferon gamma-1b - lenograstim - lithium carbonate - melatonin - penicillium glabrum - potassium carbonate - pummelo - rhodotorula rubra - silver nitrate - strychnos nux-vomica seed - sus scrofa cerebral cortex - sus scrofa stomach - sus scrofa superior gastric plexus - sus scrofa thalamus -
  • Active Ingredient(s): 4 [hp_C]/4g ACETYLCYSTEINE; 3 [hp_X]/4g BALLOTA FOETIDA; 9 [hp_C]/4g EPINEPHRINE; 4 [hp_C]/4g GLUTATHIONE; 5 [hp_C]/4g INTERFERON GAMMA-1B; 4 [hp_C]/4g LENOGRASTIM; 8 [hp_X]/4g LITHIUM CARBONATE; 15 [hp_C]/4g MELATONIN; 8 [hp_X]/4g PENICILLIUM GLABRUM; 9 [hp_C]/4g POTASSIUM CARBONATE; 3 [hp_X]/4g PUMMELO; 8 [hp_X]/4g RHODOTORULA RUBRA; 9 [hp_C]/4g SILVER NITRATE; 5 [hp_C]/4g STRYCHNOS NUX-VOMICA SEED; 4 [hp_C]/4g SUS SCROFA CEREBRAL CORTEX; 7 [hp_C]/4g SUS SCROFA STOMACH; 7 [hp_C]/4g SUS SCROFA SUPERIOR GASTRIC PLEXUS; 7 [hp_C]/4g SUS SCROFA THALAMUS
  • Administration Route(s): ORAL
  • Dosage Form(s): PELLET
  • Pharmacy Class(es): Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Allergens [CS]; Allergens [CS]; Antidote [EPC]; Antidote for Acetaminophen Overdose [EPC]; Catecholamine [EPC]; Catecholamines [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Decreased Respiratory Secretion Viscosity [PE]; Fungal Proteins [CS]; Increased Glutathione Concentration [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased IgG Production [PE]; Increased IgG Production [PE]; Interferon gamma [EPC]; Interferon-gamma [CS]; Mood Stabilizer [EPC]; Mucolytic [EPC]; Non-Standardized Fungal Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; Reduction Activity [MoA]; Seed Storage Proteins [CS]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Labeler Information

Field Name Field Value
Labeler Name: Guna spa
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:5/23/2006

Package Information

No. Package Code Package Description Billing Unit
117089-067-202 TUBE in 1 BOX (17089-067-20) / 4 g in 1 TUBE

NDC Record

Field Name Field Value Definition
PRODUCT NDC17089-067The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEANTI AGE STRESSThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEacetylcysteine - ballota foetida - epinephrine - glutathione - interferon gamma-1b - lenograstim - lithium carbonate - melatonin - penicillium glabrum - potassium carbonate - pummelo - rhodotorula rubra - silver nitrate - strychnos nux-vomica seed - sus scrofa cerebral cortex - sus scrofa stomach - sus scrofa superior gastric plexus - sus scrofa thalamus -The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMEPELLETThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE5/23/2006This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEGuna spaName of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEACETYLCYSTEINE; BALLOTA FOETIDA; EPINEPHRINE; GLUTATHIONE; INTERFERON GAMMA-1B; LENOGRASTIM; LITHIUM CARBONATE; MELATONIN; PENICILLIUM GLABRUM; POTASSIUM CARBONATE; PUMMELO; RHODOTORULA RUBRA; SILVER NITRATE; STRYCHNOS NUX-VOMICA SEED; SUS SCROFA CEREBRAL CORTEX; SUS SCROFA STOMACH; SUS SCROFA SUPERIOR GASTRIC PLEXUS; SUS SCROFA THALAMUSAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH4; 3; 9; 4; 5; 4; 8; 15; 8; 9; 3; 8; 9; 5; 4; 7; 7; 7 
ACTIVE INGRED UNIT[hp_C]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_X]/4g; [hp_C]/4g; [hp_X]/4g; [hp_C]/4g; [hp_X]/4g; [hp_X]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g; [hp_C]/4g 
PHARM CLASSESAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Antidote [EPC], Antidote for Acetaminophen Overdose [EPC], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Decreased Respiratory Secretion Viscosity [PE], Fungal Proteins [CS], Increased Glutathione Concentration [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Increased IgG Production [PE], Interferon gamma [EPC], Interferon-gamma [CS], Mood Stabilizer [EPC], Mucolytic [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Plant Proteins [CS], Reduction Activity [MoA], Seed Storage Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 12/6/2025

Previous Code
Next Code